ASX/IVR (ASX/IVR)

Australian Securities Exchange: ASX/IVR · AUD

A$0.04

+0.00 (0.0%)· Recorded snapshot

Market cap	102.3M
Net income (ttm)	-2.5M
EPS (ttm)	-A$0.00
Shares out	2.6B
Volume	5,141,474
Beta	1.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -2.5M
EPS (ttm): -A$0.00
Market cap: 102.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.6

P25 n/aP50 n/aP75 n/a

ROIC-3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/IVR indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

AUD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-18
Enterprise value	AUD 43.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2005
Industry	Other Precious Metals & Mining
Is primary listing	Yes
ISIN number	AU000000IVR6
Last earnings date	2025-09-24
Last refreshed	2026-10-30
Market cap	AUD 102.3M
Price	AUD 0.04
Price currency	AUD
Sector	Materials
SIC code	1000
Stock price date	2026-10-30
Symbol	asx/IVR
Website	https://investres.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.09%
FCF / EV yield	-16.35%
FCF yield	-7.01%
Industry forward P/E	107.96x
P/B ratio	1.04x
Price / tangible book value	1.04x
Sector forward P/E	15.63x
Sector P/E	22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-2.96%
ROA (5Y)	-4.59%
ROCE	-3.39%
ROE	-3.63%
ROE (5Y)	-6.34%
ROIC	-3.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -6.2M
Depreciation and amortization	AUD 140,162
EBIT	AUD -3.3M
EBITDA	AUD -3.2M
EPS	AUD -0.00
FCF per share	AUD -0.00
Financing cash flow	AUD 60.2M
Free cash flow	AUD -7.2M
Free cash flow minus SBC	AUD -8.4M
Investing cash flow	AUD -5.6M
Net cash flow	AUD 53.7M
Net income	AUD -2.5M
Operating cash flow minus SBC	AUD -2.2M
Operating income	AUD -3.3M
Stock-based compensation	AUD 1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.04
Debt / equity	0
Long-term assets	AUD 41.2M
Long-term liabilities	AUD 224,524
Net cash (debt)	AUD 58.4M
Net cash / market cap	57.14%
Net cash growth	1,092.66%
Net debt / equity	-0.6
Piotroski F-Score	2
Property, plant and equipment	AUD 40.1M
Shareholders' equity	AUD 98.2M
Tangible book value	AUD 98.2M
Tangible book value per share	AUD 0.04
Total assets	AUD 101.1M
Total cash	AUD 58.8M
Total debt	AUD 315,200
Total liabilities	AUD 2.9M
WACC	12.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 59.9M
Current liabilities	AUD 2.7M
Current ratio	22.53
Net working capital	AUD -1.4M
Quick ratio	22.37
Working capital	AUD 57.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-29.68%
Shareholder yield	-29.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	14.71%
10Y return CAGR	1.38%
10Y total return	14.71%
150-day SMA	AUD 0.05
15Y price change	-72.69%
15Y return CAGR	-8.05%
15Y total return	-71.59%
1D price change	0%
1M price change	-20.41%
1M total return	-20.41%
1W price change	-2.5%
1W total return	-2.5%
1Y price change	-23.53%
1Y return CAGR	-23.54%
1Y total return	-23.53%
20-day SMA	AUD 0.04
200-day SMA	AUD 0.07
3M price change	-2.5%
3M total return	-2.5%
3Y price change	-4.88%
3Y return CAGR	-1.65%
3Y total return	-4.88%
50-day SMA	AUD 0.05
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.17
52-week high date	2026-01-27
52-week low	AUD 0.04
52-week low date	2026-10-30
5Y price change	-45.07%
5Y return CAGR	-11.29%
5Y total return	-45.07%
6M price change	-36.07%
6M total return	-36.07%
All-time high	AUD 0.43
All-time high date	2012-03-01
All-time low	AUD 0.01
All-time low date	2019-05-02
Average true range (ATR)	AUD 0.00
Average volume	4.4M
Beta (1Y)	3.51
Beta (2Y)	2.91
Beta (5Y)	1.45
Change from 52-week high	-76.36%
Change from 52-week low	2.63%
Change from all-time high	-90.9%
Change from all-time low	457.14%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 200,517
High price	AUD 0.04
Low price	AUD 0.04
Monthly RSI	45.24
Open price	AUD 0.04
Position in 52-week range	50%
Previous close	AUD 0.04
Price vs 150-day SMA	-26.28%
Price vs 20-day SMA	-11.56%
Price vs 200-day SMA	-40.46%
Price vs 50-day SMA	-20.89%
Relative volume	1.18
RSI	30.77
Sharpe ratio	0.2
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.23
Sortino ratio	0.36
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.44
Volume	5.1M
Weekly RSI	37.36
YTD price change	-73.1%
YTD total return	-73.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.4B
Shares change (QoQ)	29.16%
Shares change (YoY)	29.68%
Shares held by insiders	3.27%
Shares held by institutions	16.17%
Shares outstanding	2.6B

Deeper analysis on ASX/IVR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/IVR report

Is a complete ASX/IVR research report available?

No complete published report is available for asx/IVR (ASX/IVR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/IVR (ASX/IVR)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/IVR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/IVR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/IVR

Frequently asked questions